186347-67-1 Usage
Uses
Used in Pharmaceutical Research:
1-(3,4-DIFLUOROPHENYL)CYCLOPROPANECARBOXYLIC ACID is used as a chemical scaffold for drug design and discovery due to its unique structural features and potential biological activities. The presence of phenyl and carboxylic acid moieties in the molecule allows for possible interactions with biological targets, facilitating the development of new drugs or pharmaceutical products.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, 1-(3,4-DIFLUOROPHENYL)CYCLOPROPANECARBOXYLIC ACID is utilized for its potential to contribute to the discovery of novel therapeutic agents. Its structural characteristics and the ability to engage with biological targets make it a valuable compound for exploring new avenues in drug development.
Research on the properties and potential applications of 1-(3,4-DIFLUOROPHENYL)CYCLOPROPANECARBOXYLIC ACID is ongoing, and it may find use in various industries in the future, including but not limited to pharmaceuticals, agrochemicals, and materials science.
Check Digit Verification of cas no
The CAS Registry Mumber 186347-67-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,8,6,3,4 and 7 respectively; the second part has 2 digits, 6 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 186347-67:
(8*1)+(7*8)+(6*6)+(5*3)+(4*4)+(3*7)+(2*6)+(1*7)=171
171 % 10 = 1
So 186347-67-1 is a valid CAS Registry Number.
186347-67-1Relevant articles and documents
Chiral Bidentate Boryl Ligand Enabled Iridium-Catalyzed Enantioselective C(sp3)-H Borylation of Cyclopropanes
Shi, Yongjia,Gao, Qian,Xu, Senmiao
, p. 10599 - 10604 (2019)
We herein report an Ir-catalyzed enantioselective C(sp3)-H borylation of cyclopropanecarboxamides using a chiral bidentate boryl ligand for the first time. A variety of substrates with α-quaternary carbon centers could be compatible in this reaction to provide β-borylated products with good to excellent enantioselectivities. We have also demonstrated that the borylated products can be used as versatile precursors engaging in stereospecific transformations of C-B bonds, including the synthesis of a bioactive compound Levomilnacipran.
